Access to anti-retroviral drugs, female (%) in United Kingdom
United Kingdom: Access to anti-retroviral drugs, female (%) was 96.0% in 2023. ▲ Rising
Latest (2023)
96.0%
Change on year
up 5.5%
World rank
14th
of 141 countries
All-time high
96.0%
in 2023
All-time low
87.0%
in 2016
Years of data
8
2016–2023
Access to anti-retroviral drugs, female in United Kingdom, 2016–2023
Source: UNAIDS estimates. Measured in %.
Analysis
In 2023, access to anti-retroviral drugs, female in United Kingdom stood at 96.0%. That is the highest value across all 8 years on record.
The figure is up 5.5% on the previous year and up 10.3% over ten years.
United Kingdom ranks 14th of 141 countries on this measure, in the top 10%.
Access to anti-retroviral drugs, female (%) in United Kingdom, year by year
| Year | % | Change |
|---|---|---|
| 2016 | 87.0% | — |
| 2017 | 88.0% | +1.1% |
| 2018 | 88.0% | +0.0% |
| 2019 | 89.0% | +1.1% |
| 2020 | 88.0% | -1.1% |
| 2021 | 88.0% | +0.0% |
| 2022 | 91.0% | +3.4% |
| 2023 | 96.0% | +5.5% |
United Kingdom compared with similar countries
- United Kingdom's 96.0% is above the median for high income countries, which is 82.0%, 1.2× the median. (39 countries reporting)
- United Kingdom's 96.0% is above the median for Europe & Central Asia, which is 83.0%, 1.2× the median. (33 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 88.0% | 87.0% | 89.0% | 4 |
| 2020s | 90.8% | 88.0% | 96.0% | 4 |
Countries ranked near United Kingdom
More gender data for United Kingdom
- Child population (UN estimates and projections) 11,226 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.9161 % change on previous year (2030)
- Population 60,060 (2030)
- Working-age population (UN estimates and projections) 60,060 (2030)
- Population (UN estimates and projections), annual growth rate 0.7034 % change on previous year (2030)
- Age population, age 00, female, interpolated 335,907 (2025)
- Age population, age 00, male, interpolated 353,938 (2025)
- Age population, age 01, female, interpolated 340,922 (2025)
- Age population, age 01, male, interpolated 359,075 (2025)
- Age population, age 02, female, interpolated 343,706 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in United Kingdom?
- Access to anti-retroviral drugs, female in United Kingdom was 96.0% in 2023, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in United Kingdom?
- The highest recorded value was 96.0% in 2023.
- What is the lowest access to anti-retroviral drugs, female recorded in United Kingdom?
- The lowest recorded value was 87.0% in 2016.
- How does United Kingdom rank for access to anti-retroviral drugs, female?
- United Kingdom ranks 14th out of 141 countries with data for 2023.
- Is access to anti-retroviral drugs, female rising or falling in United Kingdom?
- Over the last ten years it is up 10.3%. The long-run trend across the full record is rising.
- Where does this United Kingdom data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 8 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.